Mr. Roberts has 30 years of experience in significant leadership roles and executive management at large corporations, mid-caps and start-up companies in the medical technology, device and biotech sectors. Over Mr. Roberts’ career in the medical diagnostics and healthcare technology industries, he has been responsible for billion-dollar global healthcare brands and the successful commercialization of numerous medical device products.

Dr. Gdovin received his Ph.D. in Physiology at Dartmouth College in Hanover, NH, and completed his post-doctoral fellowship at The University of Calgary Faculty of Medicine in Canada. From 1997 to 2018, he was a Professor of Physiology at UTSA. Dr. Gdovin is the inventor of, and recognized expert in the ability to disrupt intracellular pH regulation in cancer to cause cancer cell death through Light-Activated Intracellular Acidosis.

Mr. Espenhover is an entrepreneur and dedicated CPA with over 30 years’ experience in providing accounting, tax, and business consulting services to a diverse set of businesses. Since 1988, he has been a CPA under the Texas State Board of Accountancy. Mr. Espenhover is also a member of the American Institute of Certified Public Accountants. In 1999, He became a Shareholder and Partner with Davidson Freedle Espenhover & Overby, P.C.

Dr. Harald Stock is a healthcare entrepreneur, investor, board director and serial CEO. After obtaining his Ph.D. in Inorganic Chemistry from Heidelberg University in 1997, he spent over ten years in Big Pharma / Med. Tech. at Roche and Johnson & Johnson. Dr. Stock is a board member at Cambridge MA-based Quantum Diamond Technologies and is the co-founder of CognifiSense, a Silicon Valley based Virtual Reality Pain Therapy startup.